XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 8/9/2012 11:16:41 AM : Underperform Start Price: $8.53 XNPT Score: -4.19

Price too high for the profit they are not making

Featured Broker Partners


Advertisement